| (単位:百万ドル) | 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | 2024/3 |
|---|---|---|---|---|---|---|
| 売上高 | 1,074 | 835 | 482 | 337 | 232 | 160 |
| 売上成長率(%) | - | -22.2 | -42.3 | -30.0 | -31.2 | -30.9 |
| 売上原価 | 313 | 293 | 183 | 159 | 113 | 91 |
| 研究開発費 | 236 | 171 | 103 | 82 | 37 | 26 |
| 営業利益 | -86 | -293 | -66 | -106 | -28 | -11 |
| 営業利益率 (%) | -35.0 | -13.6 | -31.3 | -11.8 | -6.8 | |
| 経常(税引前)利益 | -76 | -299 | -50 | -104 | -28 | -10 |
| 経常(税引前)利益率(%) | -7.1 | -35.7 | -10.2 | -30.7 | -11.9 | -5.7 |
| 法人税等合計 | -3 | -1 | 5 | -3 | -1 | -1 |
| 実効税率(%) | 0.0 | -10.5 | 2.2 | 1.0 | 2.5 | |
| 純利益 | -73 | -315 | -51 | -101 | -26 | -9 |
| 純利益率(%) | -37.6 | -10.4 | -29.9 | -11.2 | -5.1 | |
| 一株あたり利益 | -0.13 | -0.12 | -0.02 | -0.04 | -0.01 | 0 |
| 希薄化後一株あたり利益 | -0.13 | -0.12 | -0.02 | -0.04 | -0.01 | 0 |
| EBITDA | 45 | 285 | 227 | 38 | -1 | |
| EBITDAマージン(%) | 5.5 | 59.2 | 67.5 | 16.4 | -0.6 |